Canada markets closed

Agios Pharmaceuticals, Inc. (8AP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
30.20-2.00 (-6.21%)
At close: 08:07AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
29,403
26,823
14,240
0
0
Cost of Revenue
2,954
2,881
1,704
0
2,805
Gross Profit
26,449
23,942
12,536
0
200,391
Operating Expenses
Research Development
296,845
295,526
279,910
256,973
220,811
Selling General and Administrative
122,550
119,903
121,673
121,445
115,105
Total Operating Expenses
419,395
415,429
401,583
378,418
335,916
Operating Income or Loss
-392,946
-391,487
-389,047
-378,418
-335,916
Interest Expense
-
-
-
-
17,832
Total Other Income/Expenses Net
6,185
6,055
144,453
21,072
-
Income Before Tax
-352,619
-352,088
-231,801
-356,510
-329,305
Income from Continuing Operations
-352,619
-352,088
-231,801
-356,510
-329,305
Net Income
-352,619
-352,088
-231,801
1,604,715
-327,370
Net Income available to common shareholders
-352,619
-352,088
-231,801
1,604,715
-327,370
Basic EPS
26.55
-6.33
-4.23
26.55
-4.74
Diluted EPS
26.55
-6.33
-4.23
26.55
-4.74
Basic Average Shares
60,447
55,651
54,789
60,447
68,998
Diluted Average Shares
60,447
55,651
54,789
60,447
68,998